Growing Awareness Pertaining To Various Treatment Options Available Is Expected To Drive Pancreatic Cancer Treatment Market Growth Till 2025:Grand View Research,Inc.
The global pancreatic cancer treatment market is expected to
reach USD 4.2 billion in 2025, according to a new report by Grand View
Research, Inc. Increasing tobacco consumption, smoking, obesity, and growing
awareness pertaining to various treatment options available are propelling the
market growth at a global level. The peak incidence of pancreatic cancer is seen
in the age group of 65 to 75 years. Thus, growing geriatric population is also
expected to drive the growth during the forecast period.
According to an article published
in the National Center for Biotechnology Information in 2015, pancreatic cancer
is one of the most dangerous malignancies and is the fourth most common cause
of cancer deaths in the U.S. Furthermore, pancreatic cancer is expected to be
the second common cause of death in the U.S., by 2030. These factors together
would propel the market growth in the forecast period.
Browse full research report on Pancreatic Cancer
Treatment Market: http://www.grandviewresearch.com/industry-analysis/pancreatic-cancer-treatment-market
Further key findings from
the study suggest:
- The study suggests that exocrine cancer is by far the
most common type of pancreatic cancer accounting for more than 95% of the
overall pancreatic cancer types
- Among the treatment types, targeted therapy occupied
the largest share since it is considered as the most effective treatment
option, which blocks the growth and spread of cancer cells without
damaging healthy cells
- North America dominated the segment with the largest
revenue share in 2015 due to high adoption rate of advanced treatment
options and highly developed healthcare infrastructure
- Asia Pacific is anticipated to show a significant
growth during the forecast period, mainly due to increasing government
initiatives, growing awareness regarding the treatment options for
pancreatic cancer, and the availability of highly sophisticated medical
infrastructure for effective treatment
- Some of the major companies operating in this market
are, but are not limited to, Eli Lilly and Company; Celgene Corporation;
F. Hoffmann-La Roche AG; Amgen, Inc.; Novartis AG; PharmaCyte Biotech,
Inc.; Clovis Oncology; Teva Pharmaceutical Industries Ltd.; Merck &
Co., Inc.; and Pfizer, Inc.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the pancreatic cancer
treatment market on the basis of affected region, treatment, and region:
Pancreatic Cancer Treatment Affected Region Outlook
(Revenue, USD Million, 2014 - 2025)
- Exocrine
- Endocrine
Pancreatic Cancer Treatment Outlook (Revenue, USD
Million, 2014 - 2025)
- Chemotherapy
- Targeted
Therapy
- Others
Pancreatic Cancer Treatment Regional Outlook
(Revenue, USD Million, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- China
- Japan
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment